About BioAtla LLC
BioAtla develops Conditionally Active Biologic (CAB) antibody-drug conjugates that selectively activate in the tumor microenvironment, improving cancer targeting while reducing systemic toxicity.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to BioAtla LLC. Response typically within 48 hours.
Company Info
TypePublic
StockBCAB (NASDAQ)
Founded2007
Employees150
Revenue$20M
HQSan Diego, USA
